维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Burger AM"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications 显示文摘	Burger AM Seth AK	2004	Eur J Cancer2004，40，15：	1
2	The ubiquitin-mediated protein degradation pathway in cancer:therapeutic implications显示文摘	Burger AM Seth AK	2004	Eur J Cancer2004，40，15：	1
3	Follicle-stimulating hormone is required for quantitatively normalinhibin secretion in men显示文摘	Mclachlan RI Matsumoto AM Burger HG	1988	J Clin Endocrinol Metab1988，67，6：	1
4	MLV/HIV-pseudotyped vectors : a new treatment option for cutaneous T cell lymphomas 显示文摘	Thaler S Burger AM Sehulz T	2003	Mol Ther2003，8，5：	1
5	Final results of a phase Ⅲ trial of 5-Fu/leucovofin versus oxaliplatin versus the combination in patients with metastatic colorectal cancer following irinotecan,5-Fu,and leucovorin显示文摘	Rothenberg ML Oza AM Burger B	2003	Proc Am Soc Clin Oncol2003，22，3：	1
6	Simple bone cysts treated by multiple drill-holes显示文摘	Burgers AM Taminiau AH	1997	Acta Orthop Scand1997，68，：	1
7	The ubiquitin-mediated protein degradation pathway in cancer :therapeutic implications显示文摘	Burger AM Seth AK	2004	Eur J Cancer2004，40，15：	1
8	MLV/HIV- pseudotyped vectors: a new treatment option for cutaneous T cell lymphomas 显示文摘	Thaler S Burger AM Schulz T	2003	Mol Ther2003，8，5：	1
9	Contributions of human tumor xenografts to anticaneer drug development 显示文摘	Sausville EA Burger AM	2006	Cancer Res2006，66，7：	1
10	Inhibition of telomerase activity by cisplatin in human testicular cancer cells显示文摘	Burger AM Double JA Newell DR	1997	Eur J Cancer1997，33，4：	1
11	Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene,is associated with disease progression in breast carcinomas显示文摘	Burger AM Zhang X Li H	1998	Oncogene1998，16，：	1
12	Phase Ⅰ study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma显示文摘	Badros A Burger AM Philip S		0，，：	1
13	Therapeutic Implications of Leukemic Stem Cell Pathways显示文摘	Chumsri S Matsui W Burger AM	2007	Clin Cancer Res2007，13，221：	1
14	Establishment of a mouse xenograft model for mycosis fungoides显示文摘	Thaler S Burger AM Schulz T	2004	Exp Dermatol2004，13，7：	1
15	Therapeutic implications of leu- kemic stem cell pathways 显示文摘	Chumsri S Matsui W Burger AM	2007	Clin Cancer Res2007，13，221：	1
16	Change in pharkin etic and pharmacodynamie behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels 显示文摘	Burger AM Brandl M	2002	Cancer Chemother Pharmacol2002，49，5：	1
17	A randomized phaseⅡstudy comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed nonsmall-cell lung cancer patients:the NVALT-10study显示文摘	Aerts JG Codrington H Lankheet NA Burgers S Biesma B Dingemans AM	2013	Ann Oncol2013，24，11：	1
18	Final results of a phase Ⅲ trial of 5-FU/leucovorin Versus oxaliplatinversus the combination in patients with metastatic colorectal cancer followingirinotecan,5-FU, and leucovorin显示文摘	Rothenberg ML Oza AM Burger B	2003	Proc Am Soc Clin Oncol2003，22，3：	1
19	The Ubiquitin-media protein degradation pathway in cancer:theropeutic implications 显示文摘	BURGER AM SETHAK	2004	Eur J Cancer2004，40，9：	1
20	The ubiquitin-mediated protein degradation pathway in cancer:therapeutic implications显示文摘	Burger AM Seth AK	2004	Eur J Cancer2004，40，15：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示